Successful projects will be selected based on the following criteria:
- The quality of the hypothesis, strength of the preliminary data and the potential impact the probe or associated technology will have on health care delivery and outcomes.
- The extent to which the proposed project contributes to the Centre. This implies that each project must address the specific deliverables and the commercial aims of CPDC.
- To validate, translate and commercialize innovative imaging probes and associated technologies emerging from academic labs and research centres in Canada;
- To provide the means to obtain Health Canada approval for molecular probes and to increase the number of agents entering trials for clinical and drug development studies; and
- To attract investment in probe development to Ontario and to facilitate the creation of two new Canadian companies within the first five years of operations.
- The project demonstrates the importance of probe development for the economy of Canada and the health and well-being of Canadians, key requirements of the Networks of Centres of Excellence CECR program.
- The proposed project makes efficient and appropriate use of the Centre’s resources and expertise.
- There are measurable milestones to be completed within the proposed period of the project.
Funding allocations:
- Approved projects should seek additional funding to support research activities beyond CPDC’s involvement (based on the Centre’s services), which is limited to a maximum of two years.
- Applicants must demonstrate they are working on securing additional funding for commercialization during the first year of the project.
- Project budgets may be increased to promote team proposals, involving multiple researchers and industrial partners particularly when multiple sites are involved.
Contact us today to learn more about ISRP.
905.525.9140 x 21212
info@imagingprobes.ca
